| Bioactivity | Vicagrel is a potent, safe and orally active antiplatelet agent, which works by irreversibly inhibiting P2Y12 receptor. Vicagrel can be used for the research of blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease[1][2]. | ||||||||||||
| Invitro | Vicagrel (compound 9a) (20 μM, 30 min) activates production of the active metabolite from in vitro rat liver microsomal[1]. | ||||||||||||
| In Vivo | Vicagrel (compound 9a) (oral, 3 mg/kg) has inhibitory effect on ADP-induced platelet aggregation in rats[1].Vicagrel (oral, 1.14 mg/mL, 0-24 h) has giood preliminary pharmacokinetic with high bioavailability and low clinically effective dose[1].Vicagrel (oral, 5 g/kg, single, for 14 days) has low dose-related toxicity in mouse[1]. Animal Model: | ||||||||||||
| Name | Vicagrel | ||||||||||||
| CAS | 1314081-53-2 | ||||||||||||
| Formula | C18H18ClNO4S | ||||||||||||
| Molar Mass | 379.86 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. French, et al. Method for preparing vicagrel. Patent. WO2014040498A1. [2]. Jiaqi Shan, et al. Overcoming clopidogrel resistance: discovery of vicagrel as a highly potent and orally bioavailable antiplatelet agent. J Med Chem |
Vicagrel
CAS: 1314081-53-2 F: C18H18ClNO4S W: 379.86
Vicagrel is a potent, safe and orally active antiplatelet agent, which works by irreversibly inhibiting P2Y12 receptor.
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.